A two-centre, randomised, double-blind, double-dummy, placebo-controlled, 3-period cross-over study to evaluate the effect of treatment with repeat doses of GW274150 on the allergen-induced late asthmatic response in subjects with mild asthma.
- Registry ID
- EUCTR2004-000576-13
- Source registry
- EUCTR
- Status
- Completed
- Phase
- PHASE2
- Sponsor
- GlaxoSmithKline Research & Development Limited
- Start date
- 2004-11-03
- Completion date
- 2005-10-28
- Last update
- 2026-08-16
Conditions
Summary
To evaluate the effect of treatment with repeat oral doses of GW274150 for 14 days on the late asthmatic response (LAR) to inhaled allergen in mild asthmatic subjects compared with placebo
Locations
View on source registry